Silent information regulator 1 (SIRT1), a member of the NAD + ‐dependent class III deacetylase family, has become a new target for the prevention and treatment of DKD, seemingly regulated by polyphenolic compounds (Jin et al. 2024). This evidence concerns the gene SIRT1 and diabetic kidney disease.